{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:10:08Z","timestamp":1794946208159,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cholestatic liver injury, characterized by direct exposure of hepatocytes to retained bile components with elevated concentrations, represents a common manifestation of various hepatobiliary disorders with persistent threats to long-term patient survival despite existing therapies. As the primary route for copper elimination, cholestasis raises questions about the role of copper in cholestatic liver injury and its specific molecular mechanisms. Our single-center retrospective study revealed elevated serum copper levels in subjects with increased gamma-glutamyl transferase compared to controls. Single-cell sequencing of biliary atresia (BA) patients\u2019 cholestatic liver specimens demonstrated downregulation of FDX1, a key cuproptosis marker, in BA hepatocytes. Bile duct-ligated rats under high-copper diets exhibited accelerated liver injury, attenuated by copper chelator tetrathiomolybdate (TTM). In vitro, copper chloride\/elesclomol-induced DLAT monomer reduction and oligomerization alongside impaired lipoylation. Given the special coexistence of copper overload and accumulated bile components within the hepatic microenvironment, notably, we found that taurocholic acid potentiated hepatic copper accumulation under cholestatic conditions. Mechanistically, transcriptomic analysis implicated smoothened signaling inhibition in cuproptosis progression, with smoothened agonist (SAG) restoring DLAT expression and cellular viability. Interestingly, FDX1 overexpression enhanced cuproptosis resistance of hepatocytes through DLAT monomer stabilization and LIAS-mediated lipoylation. Cholestasis-induced copper overload drives liver injury via taurocholic acid-exacerbated and FDX1-mediated cuproptosis. Our findings propose TTM and SAG as therapeutic candidates and reveal complex FDX1 regulatory roles, suggesting novel approach for managing cholestatic liver injury.<\/jats:p>","DOI":"10.1038\/s41420-025-02861-7","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:43:10Z","timestamp":1767969790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["FDX1-mediated cuproptosis promotes cholestatic liver injury exacerbated by taurocholic acid-enhanced copper accumulation"],"prefix":"10.1038","volume":"12","author":[{"given":"Yujun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze\u2019nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-7098","authenticated-orcid":false,"given":"Qingbo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2861_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-031521-025623","volume":"19","author":"H Sutton","year":"2024","unstructured":"Sutton H, Karpen SJ, Kamath BM. Pediatric cholestatic diseases: common and unique pathogenic mechanisms. Annu Rev Pathol. 2024;19:319\u201344.","journal-title":"Annu Rev Pathol"},{"key":"2861_CR2","doi-asserted-by":"crossref","unstructured":"Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64:154\u201368.","DOI":"10.1097\/MPG.0000000000001334"},{"key":"2861_CR3","doi-asserted-by":"publisher","first-page":"E150","DOI":"10.1097\/HEP.0000000000001275","volume":"81","author":"C Levy","year":"2024","unstructured":"Levy C, Bowlus CL. Primary biliary cholangitis: personalizing second-line therapies. Hepatology. 2024;81:E150.","journal-title":"Hepatology"},{"key":"2861_CR4","doi-asserted-by":"publisher","first-page":"ii42","DOI":"10.1136\/gut.52.suppl_2.ii42","volume":"52","author":"RO Elferink","year":"2003","unstructured":"Elferink RO. Cholestasis. Gut. 2003;52:ii42\u2013ii48.","journal-title":"Gut"},{"key":"2861_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/liv.13394","volume":"37","author":"A Voiosu","year":"2017","unstructured":"Voiosu A, Wiese S, Voiosu T, Bendtsen F, M\u00f8ller S. Bile acids and cardiovascular function in cirrhosis. Liver Int. 2017;37:1420\u201330.","journal-title":"Liver Int"},{"key":"2861_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","volume":"10","author":"PKH Tam","year":"2024","unstructured":"Tam PKH, Wells RG, Tang CSM, Lui VCH, Hukkinen M, Luque CD, et al. Biliary atresia. Nat Rev Dis Prim. 2024;10:47.","journal-title":"Nat Rev Dis Prim"},{"key":"2861_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","volume":"11","author":"MP Manns","year":"2025","unstructured":"Manns MP, Bergquist A, Karlsen TH, Levy C, Muir AJ, Ponsioen C, et al. Primary sclerosing cholangitis. Nat Rev Dis Prim. 2025;11:17.","journal-title":"Nat Rev Dis Prim"},{"key":"2861_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378.","journal-title":"Signal Transduct Target Ther"},{"key":"2861_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.284.5415.805","volume":"284","author":"TD Rae","year":"1999","unstructured":"Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O\u2019Halloran TV. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science. 1999;284:805\u20138.","journal-title":"Science"},{"key":"2861_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Cz\u0142onkowska","year":"2018","unstructured":"Cz\u0142onkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Primers. 2018;4:21.","journal-title":"Nat Rev Dis Primers"},{"key":"2861_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103256","volume":"75","author":"J Sailer","year":"2024","unstructured":"Sailer J, Nagel J, Akdogan B, Jauch AT, Engler J, Knolle PA, et al. Deadly excess copper. Redox Biol. 2024;75:103256.","journal-title":"Redox Biol"},{"key":"2861_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1039\/c8mt00362a","volume":"11","author":"M Costas-Rodr\u00edguez","year":"2019","unstructured":"Costas-Rodr\u00edguez M, Van Campenhout S, Hastuti AAMB, Devisscher L, Van Vlierberghe H, Vanhaecke F. Body distribution of stable copper isotopes during the progression of cholestatic liver disease induced by common bile duct ligation in mice. Metallomics. 2019;11:1093\u2013103.","journal-title":"Metallomics"},{"key":"2861_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1124\/jpet.107.131227","volume":"325","author":"M Song","year":"2008","unstructured":"Song M, Song Z, Barve S, Zhang J, Chen T, Liu M, et al. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther. 2008;325:409\u201316.","journal-title":"J Pharmacol Exp Ther"},{"key":"2861_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22:46.","journal-title":"Mol Cancer"},{"key":"2861_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","volume":"44","author":"L Yang","year":"2023","unstructured":"Yang L, Yang P, Lip GYH, Ren J. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci. 2023;44:573\u201385.","journal-title":"Trends Pharmacol Sci"},{"key":"2861_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122223","volume":"334","author":"Z Tian","year":"2023","unstructured":"Tian Z, Jiang S, Zhou J, Zhang W. Copper homeostasis and cuproptosis in mitochondria. Life Sci. 2023;334:122223.","journal-title":"Life Sci"},{"key":"2861_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, Ding P, Song Y, Zhou J, Chen X, Peng C, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75:103302.","journal-title":"Redox Biol"},{"key":"2861_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523.","journal-title":"Nat Commun"},{"key":"2861_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"2861_CR20","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","volume":"18","author":"BL Woolbright","year":"2012","unstructured":"Woolbright BL. Jaeschke H. Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol. 2012;18:4985\u201393.","journal-title":"World J Gastroenterol"},{"key":"2861_CR21","doi-asserted-by":"publisher","first-page":"s53","DOI":"10.5604\/01.3001.0010.5497","volume":"16","author":"JP Arab","year":"2017","unstructured":"Arab JP, Cabrera D, Arrese M. Bile acids in cholestasis and its treatment. Ann Hepatol. 2017;16:s53\u2013s57.","journal-title":"Ann Hepatol"},{"key":"2861_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai S-Y, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Asp Med. 2017;56:45\u201353.","journal-title":"Mol Asp Med"},{"key":"2861_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0168-8278(03)00214-9","volume":"39","author":"MH Schoemaker","year":"2003","unstructured":"Schoemaker MH, Gommans WM, Conde de la Rosa L, Homan M, Klok P, Trautwein C, et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol. 2003;39:153\u201361.","journal-title":"J Hepatol"},{"key":"2861_CR24","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1074\/jbc.M804585200","volume":"284","author":"C Rust","year":"2009","unstructured":"Rust C, Wild N, Bernt C, Vennegeerts T, Wimmer R, Beuers U. Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. J Biol Chem. 2009;284:2908\u201316.","journal-title":"J Biol Chem"},{"key":"2861_CR25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.20246","volume":"39","author":"MH Schoemaker","year":"2004","unstructured":"Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology. 2004;39:1563\u201373.","journal-title":"Hepatology"},{"key":"2861_CR26","doi-asserted-by":"publisher","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","volume":"6","author":"J Trottier","year":"2011","unstructured":"Trottier J, Bia\u0142ek A, Caron P, Straka RJ, Milkiewicz P, Barbier O. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS One. 2011;6:e22094.","journal-title":"PLoS One"},{"key":"2861_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","volume":"32","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Hong J-Y, Rockwell CE, Copple BL, Jaeschke H, Klaassen CD. Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int. 2012;32:58\u201369.","journal-title":"Liver Int"},{"key":"2861_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jchromb.2005.08.016","volume":"826","author":"I Burkard","year":"2005","unstructured":"Burkard I, von Eckardstein A, Rentsch KM. Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;826:147\u201359.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2861_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gutjnl-2020-323345","volume":"71","author":"A Salhab","year":"2022","unstructured":"Salhab A, Amer J, Lu Y, Safadi R. Sodium+\/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. Gut. 2022;71:1373\u201385.","journal-title":"Gut"},{"key":"2861_CR30","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/hep4.2003","volume":"6","author":"Z Farhat","year":"2022","unstructured":"Farhat Z, Freedman ND, Sampson JN, Falk RT, Koshiol J, Weinstein SJ, et al. A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer. Hepatol Commun. 2022;6:2391\u20139.","journal-title":"Hepatol Commun"},{"key":"2861_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","volume":"64","author":"A Baghdasaryan","year":"2016","unstructured":"Baghdasaryan A, Fuchs CD, \u00d6sterreicher CH, Lemberger UJ, Halilbasic E, P\u00e5hlman I, et al. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J Hepatol. 2016;64:674\u201381.","journal-title":"J Hepatol"},{"key":"2861_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","volume":"42","author":"EA Rowland","year":"2018","unstructured":"Rowland EA, Snowden CK, Cristea IM. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr Opin Chem Biol. 2018;42:76\u201385.","journal-title":"Curr Opin Chem Biol"},{"key":"2861_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56171-8","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Ma C, Xu Y, Chang S, Wu H, Yan C, et al. Dynamics of the mammalian pyruvate dehydrogenase complex revealed by in-situ structural analysis. Nat Commun. 2025;16:917.","journal-title":"Nat Commun"},{"key":"2861_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature25003","volume":"552","author":"Y Wang","year":"2017","unstructured":"Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, et al. KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552:273\u20137.","journal-title":"Nature"},{"key":"2861_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:681\u20139.","journal-title":"Nat Chem Biol"},{"key":"2861_CR36","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41565-024-01784-1","volume":"19","author":"Y Liao","year":"2024","unstructured":"Liao Y, Wang D, Gu C, Wang X, Zhu S, Zheng Z, et al. A cuproptosis nanocapsule for cancer radiotherapy. Nat Nanotechnol. 2024;19:1892\u2013902.","journal-title":"Nat Nanotechnol"},{"key":"2861_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02828-3","volume":"22","author":"K Li","year":"2024","unstructured":"Li K, Wu L, Wang H, Fu Z, Gao J, Liu X, et al. Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy. J Nanobiotechnology. 2024;22:546.","journal-title":"J Nanobiotechnology"},{"key":"2861_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, Basu S, Freibert S-A, Webert H, Boss L, M\u00fchlenhoff U, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19:206\u201317.","journal-title":"Nat Chem Biol"},{"key":"2861_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang X, et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res. 2023;42:142.","journal-title":"J Exp Clin Cancer Res"},{"key":"2861_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100714","volume":"5","author":"W Zhou","year":"2023","unstructured":"Zhou W, VanDuyne P, Zhang C, Liu Y, Riessen R, Barragan M, et al. Pathological bile acid concentrations in chronic cholestasis cause adipose mitochondrial defects. JHEP Rep. 2023;5:100714.","journal-title":"JHEP Rep"},{"key":"2861_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ebiom.2019.10.016","volume":"49","author":"J-O Shin","year":"2019","unstructured":"Shin J-O, Song J, Choi HS, Lee J, Lee K, Ko HW, et al. Activation of sonic hedgehog signaling by a Smoothened agonist restores congenital defects in mouse models of endocrine-cerebro-osteodysplasia syndrome. EBioMedicine. 2019;49:305\u201317.","journal-title":"EBioMedicine"},{"key":"2861_CR42","doi-asserted-by":"crossref","unstructured":"Lau S-T, Li Z, Pui-Ling Lai F, Nga-Chu Lui K, Li P, Munera JO, et al. Activation of hedgehog signaling promotes the development of mouse and human enteric neural crest cells, based on single-cell transcriptome analyses. Gastroenterology. 2019;157:1556\u201371.","DOI":"10.1053\/j.gastro.2019.08.019"},{"key":"2861_CR43","doi-asserted-by":"publisher","first-page":"105ra104","DOI":"10.1126\/scitranslmed.3002731","volume":"3","author":"VM Heine","year":"2011","unstructured":"Heine VM, Griveau A, Chapin C, Ballard PL, Chen JK, Rowitch DH. A small-molecule smoothened agonist prevents glucocorticoid-induced neonatal cerebellar injury. Sci Transl Med. 2011;3:105ra104.","journal-title":"Sci Transl Med"},{"key":"2861_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02442-w","volume":"19","author":"A Vicente-Acosta","year":"2022","unstructured":"Vicente-Acosta A, Gim\u00e9nez-Cassina A, D\u00edaz-Nido J, Loria F. The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes. J Neuroinflammation. 2022;19:93.","journal-title":"J Neuroinflammation"},{"key":"2861_CR45","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki.","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"key":"2861_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0140-6736(08)60967-8","volume":"372","author":"Organ trafficking and transplant tourism, and commercialism.","year":"2008","unstructured":"Organ trafficking and transplant tourism, and commercialism. The declaration of Istanbul. Lancet. 2008;372:5\u20136.","journal-title":"Lancet"},{"key":"2861_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3350\/cmh.2016.0032","volume":"22","author":"JH Jun","year":"2016","unstructured":"Jun JH, Choi JH, Bae SH, Oh SH, Kim GJ. Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation. Clin Mol Hepatol. 2016;22:372\u201381.","journal-title":"Clin Mol Hepatol"},{"key":"2861_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/BTER:88:3:255","volume":"88","author":"S Yu","year":"2002","unstructured":"Yu S, van der Meer R, Beynen AC. Excessive hepatic copper accumulation in jaundiced rats fed a high-copper diet. Biol Trace Elem Res. 2002;88:255\u201369.","journal-title":"Biol Trace Elem Res"},{"key":"2861_CR49","doi-asserted-by":"publisher","first-page":"R1174","DOI":"10.1186\/ar1801","volume":"7","author":"A Omoto","year":"2005","unstructured":"Omoto A, Kawahito Y, Prudovsky I, Tubouchi Y, Kimura M, Ishino H, et al. Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats. Arthritis Res Ther. 2005;7:R1174\u2013R1182.","journal-title":"Arthritis Res Ther"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02861-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:04:28Z","timestamp":1768165468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02861-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02861-7","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were conducted in strict accordance with the ethical guidelines of the Ethical Committee of the Sixth Affiliated Hospital of Harbin Medical University (Approval No. LC2024-114). The investigation with laboratory records was carried out in accordance with the principles of the Declaration of Helsinki and approved by the Ethical Committee of the Sixth Affiliated Hospital of Harbin Medical University (Approval No. LC2024-114).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"12"}}